Management of patients with Streptococcus milleri brain abscesses

Journal of Infection

Volumn 52, Issue 6, 2006, Pages 443-450

  Kowlessar, P I ^a   Connell, N H O' ^a   Mitchell, R D ^a   Elliott, S ^a   Elliott, T S J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Brain abscess; Cefotaxime; Streptococcus milleri

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; DEXAMETHASONE; METRONIDAZOLE; PENICILLIN G; RIFAMPICIN;

ABSCESS DRAINAGE; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ABSCESS; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; MALE; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; STREPTOCOCCUS MILLERI; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ANTI-INFECTIVE AGENTS; BRAIN ABSCESS; CAUSALITY; CEFOTAXIME; COHORT STUDIES; DRAINAGE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MILLERI GROUP; TIME FACTORS; TREATMENT OUTCOME;

EID: 33744784003     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.08.028     Document Type: Article

References (15)

1. Jansson A.K., Enblad P., and Sjolin J. Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis 23 (2004) 7-14
2. Seydoux C., and Francioli P. Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis 15 3 (1992) 394-401
3. Alderson D., Strong A.J., Ingham H.P., and Selkon J.B. Fifteen year review of the mortality of brain abscess. J Neurosurg 55 (1981) 759-799
4. Bhand A A Brain abscess-diagnosis and management. J Coll Physicians Surg Pak 14 7 (2004) 407-410
5. Sennaroglu L., and Sozeri B. Otogenic brain abscess: review of 41 cases. Otolaryngol Head Neck Surg 123 6 (2000) 751-755
6. Roche M., Humphreys H., Smyth E., Phillips J., Cunney R., McNamara E., et al. A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology. Clin Microbiol Infect 9 (2003) 803-809
7. Mathisen G.E., and Johnson J.P. Brain abscess. Clin Infect Dis 25 (1997) 763-781
8. Sjolin J., Lilja A., Eriksson N., Arneborn P., and Cars O. Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clin Infect Dis 17 (1993) 857-863
9. Gomez J., Poza M., Martinez M., Martines J., Hernadez J.L., Martin F., et al. Los abscesos cerebrales en un hospital general. Analisis de 66 casos consecutivos. Med Clin (Barc) 97 (1991) 641-644
10. Chun C.H., Johnson J.D., Hofstetter M., and Raff M.J. Brain abscess. A study of 45 consecutive cases. A study of 45 consecutive cases. Medicine (Baltimore) 65 (1986) 415-431
11. Sjolin J., Erikson N., Arneborn P., and Cars O. Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans. Antimicrob Agents Chemother 35 (1991) 2606-2610
12. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. The rational use of antibiotics in the treatment of brain abscess. Br J Neurosurg 14 (2000) 525-530
13. Jennett B., and Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet i (1975) 480-484
14. Whiley R.A., Beighton D., Winstanley T.G., Fraser H.Y., and Hardie J.M. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microb 30 (1992) 243-244
15. Smyth E.G., and Pallet A.P. Clinicians' guide to antibiotics. Chloramphenicol. Br J Hosp Med 39 (1988) 424-428